Sunday, March 25, 2018

Glaxo CEO Dispenses Bitter Pill to Fix R&D

Emma Walmsley, the first woman to run a major pharmaceutical company, is making sweeping changes at GlaxoSmithKline, replacing nearly half the company’s top 125 executives and shutting down two dozen clinical trials.

from WSJ.com: US Business https://ift.tt/2GrQLpu
via IFTTT

No comments:

Post a Comment